Conference Call with Granules India Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.
Conference Call with Granules India Management and Analysts on Q1FY21 Performance and Outlook. Listen to the full earnings transcript.
Conference Call with Granules India Management and Analysts on Q4FY20 and Full Year Earnings Performance and Outlook. Listen to the full earnings transcript.
Earnings Call Transcript of Discussion between Management and Analysts of Q3FY20 Performance
Opening Remarks
I am very happy to announce that we are continuing our anticipated growth plans and reap the benefits of our recent investments. Our continued performance validates our growth strategy and the trust that you and other stakeholders had placed on us. I would like to mention a few highlights during the quarter in the discussion. We have started conservatively expensing out total R&D spends including the filing fees for ANDAs and DMFs starting from Q3.
As you all know, the future growth of the company will be driven by the new DMFs and ANDAs, which we file and get approved. During this quarter, we have the expense of a total amount of 22.79 Crores. However, the past spend on R&D will be capitalized as and when we get approval and certain ANDAs that we feel may not have great potential will be amortized in a very accelerated way from time-to-time.
One such example is in this quarter, one of the ANDAs that was recently approved OXY/APAP, which is an opioid product, we felt there was a certain level of uncertainty due to taxes being imposed in certain states on suppliers and wholesalers and due to this we decided to amortize the entire spend on this ANDA, which amounts to $1.2 million.
Number two of the highlight is we are expecting a little more than 200 Crores net of TDS from the sale of both our JVs, and the Board had decided to reward the shareholders and approved a buyback of shares of the company at a price of Rs.200 per share and had earmarked an amount of 250 Crores net of the buyback tax for this purpose.
Click pdf to read full transcript
